RNRebecca Manuela Neeser

Rebecca Manuela Neeser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rebecca Manuela Neeser has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reinforcement Learning for Aligning Structure-Based Molecular Generation toward Make-on-Demand Chemical Spaces

    by Rebecca M. Neeser, Melih GökAy Yigit, Adrian W. Dobbelstein, Junwu Chen, Bruno Correia, Philippe Schwaller

    Generative models for structure-based drug design have strong potential to accelerate early-stage drug discovery by enabling the conditional generation of target-specific molecules. However, a major bottleneck is that generated compounds are frequently difficult or impossible to synthesize, limiting their direct experimental validation and utility. We address this by optimizing for membership in make-on-demand chemical libraries, ensuring that generated molecules can be directly purchased and tested. To this end, we apply reinforcement learning to a pocket-conditioned generative molecular model, steering generated molecules toward two large make-on-demand spaces: Enamine REAL and Freedom 4.0. We compare an offline, preference-based strategy (direct preference optimization, DPO) and an online RL strategy (DiffusionNFT) across single-target and multi-target settings. In single-target optimization for KRAS, the fraction of unique purchasable candidates rises from 10.0% to 25.5% for Enamine REAL and from 4.3% to 12.1% for Freedom 4.0, while drug-likeness and docking-based affinity proxies are preserved. In multi-target optimization, DPO achieves consistent improvements across diverse protein targets, including a 23-fold increase for the challenging CDK4 pocket. These results demonstrate that RL alignment can substantially improve the experimental accessibility of SBDD candidates without sacrificing structural or chemical quality.

  • Open Access

    Flow-based fragment identification via binding site-specific latent representations

    by Rebecca M Neeser, Ilia Igashov, Arne Schneuing, Michael Bronstein, Philippe Schwaller, Bruno Correia

    Fragment-based drug design is a promising strategy leveraging the binding of small chemical moieties that can efficiently guide drug discovery. The initial step of fragment identification remains challenging, as fragments often bind weakly and non-specifically. We developed a protein-fragment encoder that relies on a contrastive learning approach to map both molecular fragments and protein surfaces in a shared latent space. The encoder captures interaction-relevant features and achieves strong discrimination between binding and non-binding regions, reaching ROC–area under the curve values of 0.92 on pocket surfaces and enrichment factors of 22.85 across full protein surfaces. Building on this representation, our generative method LatentFrag produces chemically realistic fragment identities and positions conditioned on the protein surface. LatentFrag improves fragment recovery over docking-based virtual screening, achieving a sampling hit rate more than four times higher at a fraction of its computational cost providing a valuable starting point for fragment hit discovery. We further show the practical utility of LatentFrag and extend the workflow to full ligand design tasks. Together, these approaches contribute to advancing fragment identification and provide valuable tools for fragment-based drug discovery.

  • Top Cited Papers
    Open Access

    Targeting protein–ligand neosurfaces with a generalizable deep learning tool

    by Anthony Marchand, Stephen Buckley, Arne Schneuing, Martin Pacesa, Maddalena Elia, Pablo Gainza, Evgenia Elizarova, Rebecca M. Neeser, Pao-Wan Lee, Luc Reymond, et al.

    Molecular recognition events between proteins drive biological processes in living systems1. However, higher levels of mechanistic regulation have emerged, in which protein–protein interactions are conditioned to small molecules2,3,4,5. Despite recent advances, computational tools for the design of new chemically induced protein interactions have remained a challenging task for the field6,7. Here we present a computational strategy for the design of proteins that target neosurfaces, that is, surfaces arising from protein–ligand complexes. To develop this strategy, we leveraged a geometric deep learning approach based on learned molecular surface representations8,9 and experimentally validated binders against three drug-bound protein complexes: Bcl2–venetoclax, DB3–progesterone and PDF1–actinonin. All binders demonstrated high affinities and accurate specificities, as assessed by mutational and structural characterization. Remarkably, surface fingerprints previously trained only on proteins could be applied to neosurfaces induced by interactions with small molecules, providing a powerful demonstration of generalizability that is uncommon in other deep learning approaches. We anticipate that such designed chemically induced protein interactions will have the potential to expand the sensing repertoire and the assembly of new synthetic pathways in engineered cells for innovative drug-controlled cell-based therapies10.


  • Open Access

    FSscore: A Personalized Machine Learning‐Based Synthetic Feasibility Score

    by Rebecca M. Neeser, Bruno Correia, Philippe Schwaller

    Determining whether a molecule can be synthesized is crucial in chemistry and drug discovery, as it guides experimental prioritization and molecule ranking in de novo design tasks. Existing scoring approaches to assess synthetic feasibility struggle to extrapolate to new chemical spaces or fail to discriminate based on subtle differences such as chirality. This work addresses these limitations by introducing the Focused Synthesizability score (FSscore), which uses machine learning to rank structures based on their relative ease of synthesis. First, a baseline trained on an extensive set of reactant‐product pairs is established, which is then refined with expert human feedback tailored to specific chemical spaces. This targeted fine‐tuning improves performance on these chemical scopes, enabling more accurate differentiation between molecules that are hard and easy to synthesize. The FSscore showcases how a human‐in‐the‐loop framework can be utilized to optimize the assessment of synthetic feasibility for various chemical applications.


  • Open Access

    Repurposing quantum chemical descriptor datasets for on-the-fly generation of informative reaction representations: application to hydrogen atom transfer reactions

    by Javier E. Alfonso-Ramos, Rebecca Manuela Manuela Neeser, Thijs Stuyver

    In this work, we explore how existing datasets of quantum chemical properties can be repurposed to build data-efficient downstream ML models, with a particular focus on predicting the activation energy of hydrogen atom transfer reactions.


  • Open Access

    Targeting protein-ligand neosurfaces using a generalizable deep learning approach

    by Anthony Marchand, Stephen Buckley, Arne Schneuing, Martin Pacesa, Pablo Gainza, Evgenia Elizarova, Rebecca Manuela Neeser, Pao-Wan Lee, Luc Reymond, Maddalena Elia, et al.

    Molecular recognition events between proteins drive biological processes in living systems. However, higher levels of mechanistic regulation have emerged, where protein-protein interactions are conditioned to small molecules. Here, we present a computational strategy for the design of proteins that target neosurfaces, i.e. surfaces arising from protein-ligand complexes. To do so, we leveraged a deep learning approach based on learned molecular surface representations and experimentally validated binders against three drug-bound protein complexes. Remarkably, surface fingerprints trained only on proteins can be applied to neosurfaces emerging from small molecules, serving as a powerful demonstration of generalizability that is uncommon in deep learning approaches. The designed chemically-induced protein interactions hold the potential to expand the sensing repertoire and the assembly of new synthetic pathways in engineered cells.